Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. articles
  4. article
Expression of p53 gene in hepatocellular carcinomas induced by aflatoxin B1 with or without human hepatitis B virus in tree shrews
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 01 September 1997

Expression of p53 gene in hepatocellular carcinomas induced by aflatoxin B1 with or without human hepatitis B virus in tree shrews

  • Jianjia Su1,
  • Guozhong Qin,
  • Ruiqi Yan,
  • Dingrui Huang,
  • Chun Yang,
  • Guohua Huang &
  • …
  • Prabhakar D Lotlikar 

Experimental & Molecular Medicine volume 29, pages 177–182 (1997)Cite this article

  • 1128 Accesses

  • 4 Citations

  • Metrics details

Abstract

Using tree shrew as an animal model, our previous studies have demonstrated synergistic effects of aflatoxin B-1 (AFB(1)) and human hepatitis B virus (HHBV) in the induction of hepatocellular carcinoma (HCC). In the present study, we have examined expression of p53 gene in HCCs induced by AFB(1) with or without HHBV infection in tree shrews. Avidin-biotin-peroxidase complex immunohistochemical method with human p53-CM1 polyclonal antibody has been used to detect p53 expression in serial sections of paraffin-embedded liver and HCC tissues. Five out of 9 animals with HCCs (55.6%) induced by AFB(1) with HHBV infection and 2/3 animals with HCCs (66.7%) induced by AFB(1) alone expressed the p53 protein. Out of 18 HCCs examined, expression of p53 protein was observed in 9/10 moderately and poorly differentiated HCCs (0/8). None of the well differentiated HCCs (0/8) expressed p53 (0%). Similarly, no p53 expression was observed in either non-tumorous or hyperplastic liver tissues or nodules. These results suggest that p53 expression associated with p53 mutation is a late event occurring probably during tumor progression in AFB(1) and HHBV induced hepatocarcinogenesis in the tree shrew. This report is the first example of an experimental animal model where combination of human HBV and AFB(1)-induced HCCs demonstrate p53 expression.

Similar content being viewed by others

Hepatocellular carcinoma: signaling pathways and therapeutic advances

Article Open access 07 February 2025

AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma

Article Open access 09 August 2021

Molecular features of primary hepatic undifferentiated carcinoma

Article 23 December 2021

Article PDF

Author information

Authors and Affiliations

  1. Fels Institute for Cancer Research and Molecular Biology and Department of Biochemistry, Temple University School of Medicine, 3420 North Broad Street, Philadelphia, PA, 19140, USA

    Jianjia Su

Authors
  1. Jianjia Su
    View author publications

    Search author on:PubMed Google Scholar

  2. Guozhong Qin
    View author publications

    Search author on:PubMed Google Scholar

  3. Ruiqi Yan
    View author publications

    Search author on:PubMed Google Scholar

  4. Dingrui Huang
    View author publications

    Search author on:PubMed Google Scholar

  5. Chun Yang
    View author publications

    Search author on:PubMed Google Scholar

  6. Guohua Huang
    View author publications

    Search author on:PubMed Google Scholar

  7. Prabhakar D Lotlikar
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Su, J., Qin, G., Yan, R. et al. Expression of p53 gene in hepatocellular carcinomas induced by aflatoxin B1 with or without human hepatitis B virus in tree shrews. Exp Mol Med 29, 177–182 (1997). https://doi.org/10.1038/emm.1997.27

Download citation

  • Published: 01 September 1997

  • Issue date: 01 September 1997

  • DOI: https://doi.org/10.1038/emm.1997.27

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • hepatocellular carcinoma
  • hepatitis B
  • aflatoxin B1
  • p53 expression

This article is cited by

  • Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate

    • Yu-Qing Wu
    • Chen-Song Zhang
    • Sheng-Cai Lin

    Cell Research (2023)

  • Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma

    • Young Ik Lee
    • Sook Lee
    • Yoon Ik Lee

    Oncogene (2000)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited